Akebia Therapeutics (AKBA) Competitor Comparison
We are evaluating the key criteria listed to compare Akebia Therapeutics (AKBA) against its competitors in the Biotechnology industry.
Market Capitalization
198 / 368Gross Profits
41 / 278Total Revenue
60 / 300EBITDA
26 / 337Free Cashflow
30 / 352Quick Ratio
333 / 357Earnings per Share
53 / 359Dividend yield
0 / 6Total Cash
259 / 358Performance 3 years
221 / 368Performance 5 years
229 / 368Performance 10 years
308 / 368Linearity 3 years
217 / 368Linearity 5 years
164 / 367Linearity 10 years
277 / 368Total Rank
10 / 368Dividend Rank
338 / 368Valuation Rank
101 / 368Piotroski Rank
65 / 368Muliplier Rank
47 / 368Earnings per Share - AKBA ranking 53 / 359
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.